Hereditary hemochromatosis in the post- HFE era
Open Access
- 16 July 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 48 (3) , 991-1001
- https://doi.org/10.1002/hep.22507
Abstract
Following the discovery of the HFE gene in 1996 and its linkage to the iron overload disorder hereditary hemochromatosis (HH) there have been profound developments in our understanding of the pathogenesis of the biochemical and clinical manifestations of a number of iron overload disorders. This article provides an update of recent developments and key issues relating to iron homeostasis and inherited disorders of iron overload, with emphasis on HFE -related HH, and is based on the content of the American Association for the Study of Liver Diseases Single-Topic Conference entitled “Hemochromatosis: What has Happened After HFE ?” which was held at the Emory Convention Center in Atlanta, September 7-9, 2007. (Hepatology 2008;48:991–1001.)This publication has 149 references indexed in Scilit:
- Iron Homeostasis: Fitting the Puzzle Pieces TogetherCell Metabolism, 2008
- The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin ExpressionCell Metabolism, 2008
- Hepatitis C Virus–Induced Reactive Oxygen Species Raise Hepatic Iron Level in Mice by Reducing Hepcidin TranscriptionGastroenterology, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tardaProceedings of the National Academy of Sciences, 2007
- Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cellsProceedings of the National Academy of Sciences, 2006
- Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosisNature Genetics, 2002
- The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammationJournal of Clinical Investigation, 2002
- Stimulation of Lipid Peroxidation or 4-Hydroxynonenal Treatment Increases Procollagen α1 (I) Gene Expression in Human Liver Fat-Storing CellsBiochemical and Biophysical Research Communications, 1993
- Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary HemochromatosisNew England Journal of Medicine, 1985